Impact of Data Quality on a Specialty Pharmacy Product Launch

The consequences of not using quality data to support a specialty pharmacy product launch right can be severe – e.g., the entire sales force targeting an incomplete set of physicians or even the wrong physicians. Inaccurate data undermines key initiatives; without a foundation of accurate data governed in an appropriate way, decision-makers lose confidence in the data. Without trusted data, it can be very difficult to move forward on any data project, especially a drug launch.

Clean and consistent data supports more accurate analysis and better decisions. Pharma manufacturers with access to a large, rich, longitudinal set of patient data have a better understanding of patients, crucial for answering business questions and managing marketing and sales efforts during – and after – a specialty pharmacy product launch.

Download the Whitepaper Now